Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Applied Dna Scns (NQ: APDN )

0.1646 -0.0588 (-26.32%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Applied Dna Scns

< Previous 1 2 3 4 5 Next >
Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Schedules Fiscal 2022 First Quarter Financial Results Conference Call and Webcast for Thursday, February 10, 2022
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA to Deploy Linea™ 1.0 COVID-19 Assay for Rapid Detection of New Omicron Subvariant BA.2
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ 2.0 COVID-19 Assay and Linea™ Unsupervised At-Home Sample Collection Kit
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Announces Continued Momentum in COVID-19 Testing Demand
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Receives New York State Department of Health Conditional Approval for Linea™ 2.0 COVID-19 Assay as Laboratory Developed Test
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA and Stratum Reservoir (Isotech) Sign Memorandum of Understanding to Leverage Isotopic Analysis for Enhanced DNA-Based Cotton Authenticity and Provenance
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Reports Fourth Quarter and Full Fiscal Year 2021 Financial Results, Continuing Momentum in Diagnostic Testing
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Advances Cotton Genomics-based Methodology for Determination of Authenticity and Provenance
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Schedules Fourth Quarter and Full Fiscal Year 2021 Financial Results Conference Call and Webcast for Thursday, December 9, 2021
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Announces Strategy to Address Omicron SARS-CoV-2 Variant, Introduces Linea™ 2.0 COVID-19 Assay Kit
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Subsidiary LineaRx Receives Repeat Orders for LinearDNA, Adds Federally Funded Cancer Research Laboratory as CRO Customer
From Applied DNA Sciences, Inc.
Via Business Wire
Research Publication Demonstrates Utility of Applied DNA’s LinearDNA™ in Non-Viral CAR T Manufacturing Systems
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ SARS-CoV-2 Mutation Panel
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA and CLEARED4 Offer Fast, Cost-Effective and Turnkey Integrated Solution for Compliance with OSHA Mandate for COVID-19 Vaccination and Testing
From Applied DNA Sciences, Inc.
Via Business Wire
Ganesha Ecosphere and Applied DNA to Deploy CertainT® Platform to Secure Recycled Polyester Supply Chain
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Implements safeCircle™ COVID-19 Testing Program at Sarah Lawrence College
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Receives Purchase Orders Totaling $1.6 Million to Tag Textile Fibers
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Announces CertainT® Platform Support for TruTrace StrainSecure™ 2.0 for Next Generation Cannabis Tagging, Testing and Tracking
From Applied DNA Sciences, Inc.
Via Business Wire
CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Collaborates to Launch Cutting-Edge Global Cannabis Product Validation, Authentication Platform
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
Applied DNA Enters into Master Services Agreement with Flora Growth for Cannabis Validation and Authentication, Secures First Statement of Work Contract
From Applied DNA Sciences, Inc.
Via Business Wire
Flora Growth Launches Cutting-Edge Global Cannabis Distribution Strategy, Implements Pharmaceutical Standards For Its Supply Chain
From Flora Growth Corp.
Via Business Wire
Applied DNA to Participate at H.C. Wainwright 23rd Annual Global Investment Conference
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Awarded Suffolk County Community College COVID-19 Testing Contract
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Announces Third Quarter Fiscal 2021
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Schedules Fiscal 2021 Third Quarter Financial Results Conference Call and Webcast for Thursday, August 12, 2021
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Awarded The City University of New York (CUNY) COVID-19 Testing Contract
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Sciences and A&E Introduce Anti-Counterfeiting Technology for Sustainable Sewing Threads
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Reports Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort Against B.1.1.7, P1, and B.1.526 Variants and Sets August 2021 Mink Challenge Trial Launch
From Applied DNA Sciences, Inc.
Via Business Wire
Applied DNA Adds First Summer Camp for safeCircle Pooled COVID-19 Surveillance Testing
From Applied DNA Sciences, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.